Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome Patients

Completed · Phase 4

Conditions studied: Acute Coronary Syndrome

In brief

The purpose of this study is to assess the pharmacodynamic effect of ticagrelor in ACS patients undergoing an Ad Hoc PCI

Key facts

Study ID

NCT01603082

Run by

AstraZeneca

People needed

343

Starts

2012-07-01

Expected to finish

2014-06-01

Last updated by the study team

2015-12-11

Who can join

Age: 18 and older, up to 130. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Provision of signed and dated informed consent before initiation of any study-related procedures
• Male or female patients aged 18 years or older
• Documented acute coronary syndrome and troponin negative and undergoing Ad Hoc percutaneous coronary intervention (PCI)
• Females must be post menopausal or surgically sterile
• Taking aspirin as an anti-platelet medication

You may not qualify if…

• Use of any thienopyridine or ticagrelor within 7 days prior to randomization
• Any indication for oral anticoagulant (e.g., atrial fibrillation, mitral stenosis or prosthetic heart valve)
• Contraindication that ticagrelor or clopidogrel should not be administered Patient requires dialysis
• History of intolerance or allergy to aspirin

Where it is running

• Research Site — Birmingham, Alabama, United States
• Research Site — San Francisco, California, United States
• Research Site — Washington D.C., District of Columbia, United States
• Research Site — Jacksonville, Florida, United States
• Research Site — Ypsilanti, Michigan, United States
• Research Site — Minneapolis, Minnesota, United States
• Research Site — Tupelo, Mississippi, United States
• Research Site — North Kansas City, Missouri, United States
• Research Site — Belleville, New Jersey, United States
• Research Site — New York, New York, United States
• Research Site — The Bronx, New York, United States
• Research Site — Greensboro, North Carolina, United States
• Research Site — Cincinnati, Ohio, United States
• Research Site — Oklahoma City, Oklahoma, United States
• Research Site — Tyler, Texas, United States
• Research Site — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.